STIM earnings: real EPS beat/miss history, analyst consensus Buy, P/E -3.57. Updated 2026-07-23.
Neuronetics (STIM) Research Hub
Neuronetics (STIM) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-09-11, shares last closed at 3.03 USD (-0.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.57, market cap 0.13B. This hub links to the full technical, earnings and options research available for STIM.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.03 USD (-0.33%) |
| 52-week range | 1.19 USD – 3.44 USD |
| Trend regime | Range |
| 14-day RSI | 65.3 (Bullish) |
| Trailing P/E | -3.57 |
| Market cap | 0.13B |
| Dividend yield | 0.00% |
Available research for STIM
Covered Call on STIM: how it works, illustrative setup around the real 3.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on STIM: how it works, illustrative setup around the real 3.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on STIM: how it works, illustrative setup around the real 3.03 USD price, max profit/loss, breakeven and when to use it. Educational.
STIM technical analysis: range, last 3.03 USD, RSI 65.3, 52w range 1.19 USD–3.44 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is STIM in?
Neuronetics (STIM) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is STIM in an uptrend or downtrend?
As of 2026-09-11, STIM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is STIM's trailing P/E ratio?
STIM's trailing P/E is -3.57, with a market cap of 0.13B. See the earnings research page for full valuation detail.